Markers of oxidative damage and antioxidant enzyme activities as predictors of morbidity and mortality in patients with chronic heart failure

Journal of Cardiac Failure

Volumn 18, Issue 6, 2012, Pages 493-501

  Radovanovic, Slavica ^a   Savic Radojevic, Ana ^b   Pljesa Ercegovac, Marija ^b   Djukic, Tatjana ^b   Suvakov, Sonja ^b   Krotin, Mirjana ^a,b   Simic, Dragan V ^b,c   Matic, Marija ^b   Radojicic, Zoran ^d   Pekmezovic, Tatjana ^b   Simic, Tatjana ^b  

^a Medical Center Bezanijska Kosa   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

glutathione peroxidase; malondialdehyde; Oxidative stress; reactive carbonyl derivatives; remodeling

Indexed keywords

CARBONYL DERIVATIVE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; REACTIVE CARBONYL DERIVATIVE; SUPEROXIDE DISMUTASE; THIOL GROUP; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HEART VENTRICLE REMODELING; HUMAN; ISCHEMIC CARDIOMYOPATHY; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OXIDATIVE STRESS; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE PEROXIDASE; HEART FAILURE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; OXIDOREDUCTASES; SUPEROXIDE DISMUTASE; VENTRICULAR REMODELING;

EID: 84861646215     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2012.04.003     Document Type: Article

References (42)

1. M. Seddon, Y.H. Looi, and A.M. Shah Oxidative stress and redox signalling in cardiac hypertrophy and heart failure Heart 93 2007 903 907
2. M. Valgimigli, E. Merli, P. Malagutti, O. Soukhomovskaia, G. Cicchitelli, and A. Antelli Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction J Am Coll Cardiol 43 2004 2000 2008
3. F.J. Giordano Oxygen, oxidative stress, hypoxia and heart failure J Clin Invest 115 2005 500 508
4. X. Guo, H.K. Saini, J. Wang, S.K. Gupta, R.K. Goyal, and N.S. Dhalla Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system Expert Rev Cardiovasc Ther 3 2005 717 732
5. L.M. Freeman, J.E. Rush, P.E. Milbury, and J.B. Blumberg Antioxidant status and biomarkers of oxidative stress in dogs with congestive heart failure J Vet Intern Med 19 2005 537 541
6. C. Bergamini, M. Cicoira, A. Rossi, and C. Vassanelli Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure Eur J Heart Fail 11 2009 444 452
7. 2 J Mol Cell Cardiol 37 2004 63 70
8. M. Nonaka-Sarukawa, K. Yamamoto, H. Aoki, H. Takano, T. Katsuki, and U. Ikeda Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress Heart 89 2003 871 874
9. C.R. Diaz-Velez, S. Garcia Castineiras, E. Mandoza Ramos, and E. Hernández-López Increased malondialdehide in peripheral blood of patients with congestive heart failure Am Heart J 131 1996 146 152
10. S. Radovanovic, M. Krotin, D.V. Simic, J. Mimic-Oka, A. Savic-Radojevic, and M. Pljesa-Ercegovac Markers of oxidative damage in chronic heart failure: Role in disease progression Redox Rep 13 2008 109 116
11. T. Tsutsui, T. Tsutamoto, A. Wada, K. Maeda, N. Mabuchi, and M. Hayashi Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure J Am Coll Cardiol 39 2002 957 962
12. G. Charach, J. George, A. Afek, D. Wexler, D. Sheps, and G. Keren Antibodies to oxidized LDL as predictors of morbidity and mortality in patients with chronic heart failure J Card Fail 15 2009 770 774
13. R.T. Dean, S. Fu, R. Stocker, and M.J. Davies Biochemistry and pathology of radical-mediated protein oxidation Biochem J 324 1997 1 18
14. B. Halliwell, and J.M.C. Gutteridge Measurement of reactive species B. Halliwell, J.M.C. Gutteridge, Free Radicals in Biology and Medicine 2007 Oxford University Press 268 340
15. J. Mimic-Oka, T. Simic, M. Pljesa, N. Stupar, and S. Turkovic Oxidative modification of plasma proteins in different stages of chronic renal failure Facta Universitatis 8 2001 1 5
16. D.V. Simic, J. Mimic-Oka, M. Pljesa- Ercegovac, A. Savic-Radojevic, M. Opacic, and D. Matic Byproducts of oxidative protein damage and antioxidant enzyme activities in plasma of patients with different degrees of essential hypertension J Hum Hypertens 20 2006 149 155
17. J.F. Belch, A.B. Bridges, N. Scott, and M. Chopra Oxygen free radicals and congestive heart failure Br Heart J 65 1991 245 248
18. N.B. Schiller, P.M. Shah, M. Crawford, A. DeMaria, R. Devereux, and H. Feigenbaum Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms J Am Soc Echocardiogr 2 1989 358 367
19. R.L. Levine, J.A. Williams, E.R. Stadtman, and E. Shacter Carbonyl assays for determination of oxidatively modified proteins Methods Enzymol 233 1994 346 357
20. P.C. Jocelyn Spectrophotometric assay of thiols Methods Enzymol 143 1987 44 67
21. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and T.D. Randall Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
22. H.P. Misra, and I. Fridovich The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase J Biol Chem 247 1972 3170 3175
23. W.A. Gunzler, H. Kremers, and L. Flohe An improved coupled test procedure for glutathione peroxidase in blood Z Klin Chem Klin Biochem 12 1974 444 448
24. E. Eleuteri, F. Magno, I. Gnemmi, M. Carbone, M. Colombo, and G. La Rocca Role of oxidative and nitrosative stress biomarkers in chronic heart failure Front Biosci 14 2009 2230 2237
25. M. Boaz, Z. Matas, and A. Biro Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis Kidney Int 56 1999 1078 1083
26. B. Scott, A. Deman, P. Peeters, C. Van den Branden, and J.C. Stolear Cardiac troponin T and malondialdehyde modified plasma lipids in haemodialysis patients Nephrol Dial Transplant 18 2003 737 742
27. P. Holvoet, D. Collen, and F. Van de Werf Malondialdehyde-modified LDL as a marker of acute coronary syndromes J Am Med Assoc 281 1999 1718 1721
28. B. Shao, S. Pennathur, I. Pagani, M.N. Oda, J.L. Witztum, and J.F. Oram Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway J Biol Chem 285 2010 18473 18484
29. D. Yucel, S. Aydoqdu, M. Senes, B.C. Topkaya, and S. Nebioqlu Evidence of increased oxidative stress by simple measurements in patients with dilated cardiomyopathy Scand J Clin Lab Invest 62 2002 463 468
30. 2. Selective generation of 2-oxo-histidine at the histidine 118 J Biol Chem 269 1994 2405 2410
31. U. Landmesser, S. Spiekermann, S. Dikalov, H. Tatge, R. Wilke, and C. Kohler Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase Circulation 106 2002 3073 3078
32. M. de Lorgeril, and P. Salen Selenium and antioxidant defenses as major mediators in the development of chronic heart failure Heart Fail Rev 11 2006 13 17
33. T. Damy, M. Kirsch, L. Khouzami, P. Caramelle, P. Le Corvoisier, and F. Roudot-Thoraval Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities PLoS One 4 2009 e4871
34. Y.S. Lee, A.Y. Kim, J.W. Choi, M. Kim, S. Yasue, and H.J. Son Dysregulation of adipose glutathione peroxidase 3 in obesity contributes to local and systemic oxidative stress Mol Endocrinol 22 2008 2176 2189
35. H. Tsutsui, S. Kinugawa, and S. Matsushima Oxidative stress and mitochondrial DNA damage in heart failure Circ J 72 2008 A31 A37
36. T. Masano, S. Kawashima, R. Toh, S. Satomi-Kobayashi, M. Shinohara, and T. Takaya Beneficial effects of exogenous tetrahydrobiopterin on left ventricular remodeling after myocardial infarction in rats: the possible role of oxidative stress caused by uncoupled endothelial nitric oxide synthase Circ J 72 2008 1512 1519
37. M.C. Daniels, T. Naya, V.L. Rundell, and P.P. de Tombe Development of contractile dysfunction in rat heart failure; hierarchy of cellular events Am J Physiol Regul Integr Comp Physiol 293 2007 R284 R292
38. Y.F. Ding, G.L. Brower, Q. Zhong, D. Murray, M. Holland, and J.S. Janicki Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodeling induced by chronic volume overload in rats Clin Exp Pharmacol Physiol 35 2008 827 835
39. F. Qin, S. Lennon-Edwards, S. Lancel, A. Biolo, D.A. Siwik, and D.R. Pimentel Cardiac-specific overexpression of catalase identifies hydrogen peroxide-dependent and -independent phases of myocardial remodeling and prevents the progression to overt heart failure in G(alpha)q-overexpressing transgenic mice Circ Heart Fail 3 2010 306 313
40. S. Rajagopalan, X.P. Meng, S. Ramasamy, D.G. Harrison, and Z.S. Galis Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability J Clin Invest 98 1996 2572 2579
41. P.N. Seshiah, D.S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K.K. Griendling Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators Circ Res 91 2002 406 413
42. C.E. Berry, and J.M. Hare Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606